Pharmaceutical Distribution Company
Pharmaceutical Company

How to Start a Pharmaceutical Distribution Company

Do you know that the Indian pharma industry is the fourth biggest as far as volume is concerned? It is amongst the top 15 in the business worth worldwide ranking.

To become part of the essential journey of the pharma industry; one doesn’t have to set up a huge manufacturing unit that involves hefty investment. It is additionally possible to reap the advantages by launching a pharma distribution company which is a relatively low-cost business.

The process of starting a business isn’t very complex. Once understood well, one can deal with the procedure without hassles.

Who are these pharma distributors?

The pharma distributors are generally described as the middlemen between the drug manufacturing company and the retailers or the end-users. It is difficult to understand exactly how to begin the best pharmaceutical distribution company. However, here is the information you need in detail if you are the inexperienced one for your startup.

Legal requirements

The import, manufacturing, and distribution of drugs fall under the Drugs and Cosmetics Act, 1940. It has provisions for the categorization of drugs under different schedules. When one needs to launch the distribution business, a license must be issued from the CDSCO (Central Drug Standard Control Organization) or any similar state control body.

The individual applying for the license ought to have a degree or diploma in pharmacy from a recognized institute. There should be at least 1+ years’ experience in dealing with drugs.

GST Registration is required for launching the distribution business.

Documentation requirements:

  • Application form (in the prescribed format)
  • Covering letter with name and designation of the candidate
  • Declaration form (in the prescribed format)
  • Copy of the challan issued after submitting the fee for drug license
  • The site and key plan (outline) of the premises
  • Incorporation certificate, MOR/AOA, or partnership deed to state the constitution of the business
  • Evidence for possession (rent agreement, registration, or lease agreement)
  • Affidavit of non-conviction of chief or partners or owner
  • Affidavit for a full-time appointment of an enlisted drug pharmacist or equivalent resource

Pharmacy Inspector performs a regular assessment, and the business ought to satisfy all the norms laid by the authorities. Failing this, there is a chance of canceling the registration.

The apt space is essential for a pharma distribution company

When an application is submitted for starting a distribution organization, it is mandatory to furnish verifiable evidence of premises where the business will happen.

There must be vital infrastructure (storing and refrigeration facilities, rodent-free premises, hygiene, etc.) to protect the medicines.

Successful Business plan

Draft a business plan. It must be a savvy plan that makes the chances of success better. Do thorough research to comprehend your competitors. Assess the expenses needed to begin the company.

You should establish the organization’s structure, roles, and responsibilities. Recruit a staff of qualified and enthusiastic employees.

SWOT Analysis

Perform a SWOT analysis to comprehend the strengths and weaknesses of the proposed model.  It is similarly important to know the chances and threats. This would assist you with having an extraordinary overview of the market situation and how you can fit into it

Establish your brand in the market

Once the organization is established, it is time to promote the brand by utilizing every possible channel. It seems like a herculean task; however, it isn’t if you do it systematically.  Do the research well and put resources in marketing and advertising. Hire professionals and outsource the work. Every pharma companies know that being pharma wholesalers or pharma distributors and setting up the pharmaceutical distribution company in India and again getting the consideration from the audience is a truly difficult task. However if done once, you’ll be a successful brand in the market of pharma. By investing in marketing and advertising, you will be one bit closer to success. What you can do is get the marketing and advertising agencies on board. They can assist you with making all you required to make your brand name in the market.

This can include:

  • Logo
  • Brand image
  • Company’s goal
  • Website
  • And a marketing campaign

Budget is a must. The more you spend money, the more you will get promoted and get a return.

Finally,

This blog explains the process of starting a pharma distribution organization and taking it ahead of others. Taking the right steps, picking the right equipment, and recruiting the right team are the steps that can assist you with staying on the path of success.

JoinHub Pharma is leading manufacturers of Pharma Products that holds rich expertise as PCD Pharma Company in Ahmedabad, Gujarat, India. If you’re looking for wholesale pharma medicines then feel free to reach out to us anytime.

Simply give us a call on +91 99793 82527 or drop us a line at [email protected]

Pharmaceutical wholesalers
pharmaceutical exporters

Advantages of Purchasing Medicines from Pharmaceutical Wholesalers

With modern fast-paced life, the world is as of now facing significant health issues. Whether chronic illnesses or day-to-day ailments, the occurrence of illness is growing dramatically. Therefore, the demand for medicines is always high in the market.

However, a lot of duplicities are occurring in the pharma industry nowadays. A few retailers are selling fake medicines or hiking the prices to increase their revenues.

Henceforth, like a hospital or an independent pharmacist, it becomes important to take time before buying the medicines. To grow your pharma enterprise, you may require a variety of authentic products at reasonable prices. You additionally need an on-time supply of these items, to keep meeting the market demands.

This is where the pharmaceutical wholesalers step in. The supply of the bulk of quality products from these wholesalers can to a great extent simplify your business. Here are a couple of benefits of purchasing medicine from a pharmaceutical wholesaler:

Variety & Convenience

Are you someone who needs to jump from one store to another to find medicines at wholesale rates? The pharmaceutical wholesalers will in general stock their shops with various sorts of drugs under the same roof. This makes your task easier and saves a lot of your time. With various types of drugs in their stores, you can be assured to address each consumer’s needs.

Valuable Industrial Information

The pharmaceutical market is ever-changing. If you haven’t noticed this, then you have missed the most important update. Best pharmaceutical companies can help you with the most important information on the major changes that are probably going to affect the pharmaceutical industry.

This will empower you to make prior arrangements on your purchasing plans. For instance, if there are chances of price hikes, then you can purchase the drugs in advance.

Most Affordable Prices

The facts confirm that healthcare is quite expensive for most pharmaceutical suppliers and consumers. Along these lines, if you want to reduce expenses, you ought to surely buy drugs from wholesalers. As they sell their goods in bulk, they ensure economies of scale.

Particularly, the Indian wholesale suppliers set high standards when it comes to reasonableness. These wholesalers work together with the retailer to cater to worldwide needs. India has the highest number of US FDA approved pharma companies, which guarantees trust. The superior quality of affordable generic medicines in India is unmatched, and you should exploit to grow your business.

Room for Negotiation

Wholesalers typically throw in a discount or two to pharmacists who purchase their products regularly. Furthermore, if you are able to build a decent relationship with them, they additionally sell medicine and other items at a much lower cost.

This advantages the top pharma companies as well because they can hold their old customers to guarantee adequate business scopes. Consequently, it creates a win-win situation for both parties and you should definitely take advantage.

Deliveries

With wholesalers, you don’t have to actually go to their shop and get your medicines. Most of them offer the delivery of the products to the door. They may charge some additional fees for that, yet it is far cheaper than actually going to their place and purchasing your products.

This feature is especially helpful for cross country trades. Indeed, Indian pharmaceutical exporters can offer you one of the best export services paired with their top-notch pharma products.

How to Choose the Best Pharmaceutical Wholesaler

Since you know the advantages of pharmaceutical wholesalers, you should likewise know how to choose the right wholesaler for your business.

If you simply browse the internet, you will come across many pharmaceutical organizations that guarantee to offer the best services. But, are all these claims genuine?

Well, actually not. On the of the chance that you neglect to do your bit of research and choose the wrong company, and then you may endure significant losses. Here are a couple of things you should keep in mind while picking the right pharmaceutical wholesaler:

Know the services that they provide

You should know about all the services that these organizations offer. You should likewise know the countries they serve and the product categories they offer. For instance, JoinHub Pharma serves more than 50 countries, which include Gulf countries, South Africa, and Asia.

Check the reliability of the company

Authenticity and rich experience matter a lot in the pharma industry. Make sure that the organization has worked with the right clients and has enough insights, before associating with them. Additionally, try to contact their previous customers (if possible) and get their feedback.

Product Quality

Obviously, the company should be certified by reputed organizations, so that you can trust them with their quality. JoinHub pharma is certified by WHO, WHO-GMP, US FDA, and ISO 9001.

Delivery

Ensure that the pharmaceutical wholesaler delivers your orders on-time. Defaults have no place with regard to the pharma industry.

Contacts and Connections

An ideal wholesaler ought to have associated with multiple pharmaceutical manufacturers. This will empower the company to satisfy all the demands of their customers. Far and away superior if the company has its own manufacturing unit. For instance, JoinHub Pharma has its world-class manufacturing facility located in Gujarat, India

Reach out to JoinHub Pharma – A leading pharmaceutical company in India. Our representatives are just a call away. So don’t hesitate, call us today!

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

hand-sanitizer
Hand Sanitizer Manufacturer

Does Hand Sanitizer Work?

With the coronavirus (COVID-19) outbreak, it’s not astounding that many people are finding ways to stay safe, including stocking up on sanitizing sprays, gels, and soaps.

In any case, hand sanitizers give a convenient and compelling way to clean your hands if soap and water aren’t effectively accessible and your hands aren’t covered in visible dirt or grease. According to the 2019 decision by the FDA, hand sanitizer suppliers can advertise a product as a hand sanitizer if it contains ethyl alcohol, isopropyl alcohol (isopropanol), or benzalkonium chloride as the active ingredient.

The FDA hasn’t settled a choice on whether to categorize those three ingredients as “generally recognized as safe” since the organization doesn’t think there is adequate research to say. But at the same time, they’re not pulling the items from shelves. Ingredients other than those three have demonstrated little to no proof of being viable at killing germs and have not won the FDA’s endorsement.

How does it work?

It is executed by killing cells—not human cells. It also kills microbial cells. It depends on the utilization of 70% isopropyl alcohol, which is rubbing alcohol. That is the concentration of rubbing alcohol that is best in killing germs—it’s significantly more viable than 100%. Since it has a little bit of water in it, it enhances penetration. For infection, the best hand sanitizers work by disrupting the virus’s external coat. For a bacterium, they work by disrupting its cell film. It’s anything but a panacea, however, since certain infections lacking an outer coat (like the one that causes cruise ship diarrhea) or spore-forming microbes are not entirely defenseless.

How to Use It

When hand sanitizers accomplish work, their viability depends on several elements. Besides, to which item you use, they include:

  • How much you using
  • Appropriate procedure
  • Consistency

A few circumstances wherein utilization of a hand sanitizer might be appropriate to incorporate when you’re traveling in public transportation, have shaken hands, or contacted an animal after you’ve touched a grocery cart, etc.

To use hand sanitizer correctly
  • Put the suggested amount in the palm of one hand. (Read the manufacturer’s rules and directions.)
  • Rub your hands together including between your fingers.
  • Stop rubbing the sanitizer once your skin is dry.
Can hand sanitizer protect you from viruses?

Hand sanitizers with alcohol can prevent you from diseases– both viral and bacterial — when utilized correctly and in the correct scenarios. This implies applying a hand sanitizer that is at any rate 60% alcohol, utilizing the directed amount (read the label), focusing it in totally, and hanging tight for it to dry.

Hand sanitizer in coronavirus is suggested for use by medical care experts in clinical settings, as it’s been shown to decrease the spread of various hospital-borne bacteria and infections, including Methicillin-resistant Staphylococcus aureus (MRSA), which is viewed as a superbug.

Are all hand sanitizers created equal?

It’s essential to ensure any hand sanitizer you do utilize contains at least 60% alcohol.

Studies have likewise discovered that hand sanitizers with lower focused or non-alcohol-based hand sanitizers are not as successful at killing bacterias and germs as compared to those with 60 to 95% alcohol.

Specifically, non-alcohol-based sanitizers may not function admirably on various types of germs and could make a few germs to develop protection from the sanitizer.

Does hand sanitizer expire?

Hand sanitizer doesn’t generally expire. There will probably be an expiration date on the bottle since hand sanitizers are regulated by the FDA, which needs certain things to be on the packaging, including an expiration date. The expiration date should be the last date at which the item contains the ingredients in the amount determined on the label. Regardless of whether the hand sanitizer manufacturer has tried how long the product meets the label claim or they just came up with an arbitrary date to decide the expiration date is generally not known to consumers. (Manufacturers should direct testing, yet not all do.)

Alcohol is a shelf-stable chemical as indicated by its safety data sheet. This implies that if alcohol is kept in a sealed container at room temperature it will stay at a similar concentration for an incredibly, long time.

Be that as it may, the alcohol evaporates effectively due to its generally low boiling point, and after some time, as the bottle is opened and closed, some alcohol may getaway and the concentration of alcohol in your hand sanitizer may begin to diminish. In any case, if you keep the container closed and at room temperature, you’re probably going to have a successful item for as long you need it.

Is hand sanitizer bad for you or toxic?

Alcohols are considered to be safe for usage. It has generally no harmful effect on the skin, albeit repeated use may cause mild irritation and dryness, as per the Hazardous Substances Database. A few examinations have indicated that repeated utilization of hand sanitizer is less irritating than repeated handwashing with soap. Yet, damaged skin is more vulnerable to irritation from alcohol.

Get in touch with JoinHub Pharma – A leading hand sanitizer supplier.

We ensure that your hands stay germ-free for over long hours. Wellness and hygiene have turned out to be the need of the hour. With so many individuals realizing the need for cleanliness and healthiness, hand sanitizers in India are looked upon as a miracle product. We are a young and dynamic group of professionals based in Ahmedabad, India, and are committed to creating superior customer value by providing total scientific solutions to existing and emerging consumer needs in the health & personal care category.

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

pharma-exporters
pharmaceutical exporters

Pharma Exports from India – Key Trends and Predictions

India is known as the “pharmacy of the world”, and the biggest generic drug provider in the global market. The exports from the nation include drug formulations, herbal products, bulk drugs, surgical, intermediaries, biologicals, and Ayush. Over half of the global demands for various vaccines, nearly 40% of US demands for generics, and 25% of UK demands for all pharmaceuticals are provided by India.

Over the years, pharma exports from India have made huge progress in the worldwide markets. The nation’s potentially skilled scientists, engineers, and dedicated workforce are the motivation to gear this industry to profits. The current statistics depict that India gives over 80% of the antiretroviral drugs utilized worldwide to fight AIDS.

Key Trends and Predictions:

Based on the on-going benefits and predictions globally, by 2025 the pharma sector of India is anticipated to rise to $ 100 billion, while the market for a medical device is projected to increase to $ 25 billion. On a similar note, the nation’s biotechnology industry that includes bio-industry, bio-agriculture, biopharma, bio-services, bioinformatics is required to increase at an average growth rate of over 30% every year, such that rising to $ 100 billion by 2025.

There were changes made to the current FDI policy in the pharma sector endorsed by the Union Cabinet, wherein up to 100% FDI is permitted in the manufacturing of medical devices for specific diseases.

Low-cost manufacturing of generics, medical devices, intermediaries, supplements, and numerous other pharmaceutical exporters in India have drawn in many foreign investments to set up new manufacturing plants. This has prompted a consistent growth in the nation’s revenue production. Backing the plan, the industry has additionally gained consistent support from the government as it generates employment and contributes to the nation’s GDP.

 

A couple of the initiatives taken by the government in support of the above are:

    • According to the 2019-2020 economic survey, the government expenditure on health (wrt. GDP) flooded by 1.6% in FY20 as compared to 1.2% in FY15
    • Almost $ 1.3 billion funds will be invested in organizations for domestic manufacturing of pharma ingredients by 2023
    • The government has designated $ 4.88 billion for the National Health Mission beneficial to offer better medical access to urban and rural people
    • Under the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the government apportioned $ 915.72 million for the medical insurance scheme
    • According to the declaration made in the Union Budget or 2018-2019, The National Health Protection Scheme is the biggest government healthcare program in the world, is projected to grant a cover-up of up to Rs. 5 lakhs per family/year to get secondary & tertiary hospitalization care, profiting 100 million poor families in India
    • The National Digital Health Mission is accepted to set policies for pharmaceutical products in India available in the online market to annihilate misuse of medications and drugs
    • Aiming to platform India as the worldwide pioneer for end-to-end manufacturing of pharmaceuticals, the government of India uncovered the ‘Pharma Vision of 2020.’
Strengths of the Indian Pharmaceutical Exports

The country has one of the most minimal expenses of manufacturing and is one of the fastest-growing.

The increasing support from the government for the pharmaceutical industry and a consistent rate of growth in incomes are all working in favor of the pharma business.

There are 4 key competitive benefits of the Indian pharmaceutical industry include:

  1. Availability of raw material
  2. Low cost of innovation
  3. Extensive Distribution Network
  4. Skilled workforce

India has gifted experts and pharma professionals who are capable of the English language. This helps in the minimal effort of innovation, manufacturing compliance, and documentation.

The Generic Advantage

Indian pharmaceutical organizations fundamentally cater to the generic drug market. The primary focus of pharmaceutical exporters in India includes:

  1. Generic Drugs
  2. OTCs
  3. Patented Drugs
  4. Active Pharmaceutical Ingredients
  5. Biosimilars

India is among the biggest exporters of generic drugs universally. As per FactSet, the total Indian Research investment in generic drugs expanded by 3.8% of sales in 2010 to $12.55 billion.

 

Opportunities

 Latin America: An Opportunity for Indian Pharmaceutical Logistics

A report by financial express features some key facts and opportunities for Indian pharmaceutical exporters in the Latin American market:

In 2015 Indian exports to Latin America reached to $1063 million crossing $1billion with country-wise

Indian pharmaceutical exports to Latin America comprised 7.7% of the total in the year 2014-15. Off late, the trend in exports to Latin America has moved from bulk drugs (APIs) to the completed product.

Venezuela and Brazil are some of the vital business sectors for finished formulations while Mexico has a solid demand for bulk drugs. Latin America is additionally a rising market for Ayurvedic products – an opportunity for Indian exporters to tap.

 

The West African Market

The majority of the Indian pharmaceutical exporters see a growth opportunity in the West African market. As indicated by Mckinsey, the size of Africa’s pharmaceutical market reached $20.8 billion in 2013 when contrasted with 10 years sooner.

The survey anticipates that the size of this market will grow to become $40 – $65 billion – by the year 2020. The study estimates predictable growth in demand for prescription drugs, over the counter devices, and medicines. The report underlines the economic and infrastructure growth of African cities while likewise shows the growing activities in the healthcare sector like:

  1. Growth in the number of hospital beds and healthcare experts
  2. Government guideline and price control on medications

The study likewise proposes that local partnerships with organizations, NGOs, and governmental bodies would assist Indian pharmaceutical players to tap the growing business opportunity.

Moving forward, a few steps have been taken to decrease the cost of healthcare access for the public. The Indian government has been keen on drawing in top organizations across the world to align pharma products with the growing rate of chronic diseases, just to generate domestic sales.

Reach out to JoinHub Pharma – A leading pharmaceutical company with expertise in manufacturing high-quality, affordable generic, and branded medications.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

 

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs (including hydroxychloroquine) to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

 

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications– like hydroxychloroquine – to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

 

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

 

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Pharmaceutical Drugs
Generic Medicine Pharmaceutical Company

Do Generic Pharmaceutical Drugs Compromise on Quality?

Nowadays due to increased health problems, and high medicinal expenses people have started making a shift to generic drugs which are the same as brand-name drugs and offer almost equivalent medicinal properties. Generic pharmaceutical companies have never been as famous as branded and marketed drug companies. So people always have a question regarding are generic drugs as safe as their branded counterparts and are they effective in treatments for severe health implications.

Generic drugs are identical counterparts of branded drugs and medicines manufactured by large corporations. When the patent of any particular brand-name drug expires, other smaller pharmaceutical companies manufacture a generic version of it and sell it in the open market. Generic drugs are relatively cheaper as the companies producing it do not have to invest much time and money into the research and development stage. Because a formulation is already available, everything the company then needs is just to manufacture it and get it approved by the FDA.

How does the FDA approve Generic Medicines?
If a company wants to get its generic drug approved with the FDA’s stamp, it must manufacture a drug that can be seen as a bioequivalent of the brand-name drug previously available. The FDA allows drug manufacturers to make a change in the active ingredients of medicine for up to 20% but top generic pharmaceutical companies do not go to that extent in making changes in the drug’s composition.

Moreover, generic manufacturers also do not need to go under vigorous drug tests as the data available with the FDA for previously used brand-name drugs is used as a result. Hence generic drugs are mostly passed with smaller test cycles and datasets. This does not raise a question about the effectiveness of the drug. The FDA chooses this course just to ensure that the drugs reach the patients speedily in the market.

Are generic drugs less effective?
Generic medicines are as effective as their brand-name substitutes. The FDA ensures that every drug being sold in the market is safe and effective for its consumers whether it is a brand-name drug or a generic drug. As we know generic drugs have almost identical medical formulation and are made using the same active ingredients used in the making of branded drugs, generic drugs are hence the effective and alternative solution to most branded drugs.

Generic drugs are also tested and reviewed thoroughly almost as same as their branded counterparts; hence consumers should not be worried about the drug’s effectiveness. The FDA also saves and publishes information regarding generic drugs for almost all types of critical diseases. Some people also think that generic drugs are cheaper as they are made by smaller companies with limited on-site production facilities but in contrast, the FDA makes sure that a generic drug manufacturing unit complies with all the norms laid down by the FDA for manufacturing of medicines and drugs. It isn’t always that only smaller companies manufacture generic drugs and sell them in the market, but research shows that almost 50% of all generic drugs manufactured come from big branded companies as companies always thrive to make their medicines available to consumers on a large scale.

How to identify Generic Drugs?
Some laws suggest guidelines for generic drugs; any generic drug cannot be made to look the same as its branded counterpart. However, differentiating between a brand-name drug and a generic drug is never a big hassle. Manufacturers, to comply with the statutory guidelines laid down by the FDA and other institutions; develop generic drugs that vary in packaging, naming, colors, shapes, sizes, and many more different dimensions.

Is a Generic Drug available for every other Branded Drug?
Branded drugs have patent protection for 20 years, which provides relief to a company that no other manufacturer can make the same drug and sell it in the market. However when a patent for a branded drug has expired or is about to expire other manufacturers can get consent from the FDA and start manufacturing the drug under the prescribed guidelines for generic drug manufacturing. It is somehow difficult to find generic drugs for brand medications that have been in the market for less than 20 years, as it comes under patent protection. However, a similar medication can be found if needed.

The Market’s Boom for Generic Drugs

Today numerous ailments have drugs with their prices sky-rocketing by the passage of time. Several insurance providers now approve and pay their insurance holders for opting into generic drugs. Generic drugs have now gained a higher level of trust from people and people consider them an effective option to switch from branded medicines. This has helped the generic drugs market to grow on a rapid scale for the last few years.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Pharmaceutical export from India
pharmaceutical exporters

How to Export Medicines from India to Other Countries?

The Indian pharmaceutical industry is the third-biggest in terms of volume and thirteenth-largest in terms of value. It has established itself as a worldwide research and manufacturing hub. The Indian pharmaceutical industry is anticipated to develop at a compound yearly growth rate (CAGR) of 22.4% to touch US 55 billion dollars by 2020.

The Indian Pharmaceutical market is overwhelmed by generic drugs which establish almost 70% of the market, whereas Over the Counter medicines and patented drugs makeup 21% and 9% respectively.

PHARMACEUTICAL EXPORTS AND ADVANTAGE INDIA

  • Pharmaceutical export from India stood at US$ 17.27 billion in 2017-18 and is projected to grow by 30% to reach the US $20 billion by the year 2020.
  • Exports of pharmaceutical products together remained at US$ 10.80 billion during April-October 2018.
  • During April-October 2018, the top importers of India’s pharmaceutical products were UK (US$ 383.30 million), the USA (US$ 3.21 billion), South Africa (US$ 367.35 million), Nigeria (US$ 255.89 million), and Russia (US$ 283.33 million).
  • India is projected to rank amongst the top three pharmaceutical markets regarding incremental growth by 2022.
  • India is the biggest supplier of generic medicines around the world(20 to 22 percent of worldwide export volume)
  • India has one of the least manufacturing costs on the planet. It is lower than that of the USA and practically 50% of Europe.

Fortunately, the government of India has been very supportive, and there are many facilities and concessions are being offered to those who need to start export units.

Step-by-step guide for export of pharmaceutical products and medicines from India

  • Establish a company or firm that will manufacture or advertise pharmaceutical products
  • Import Export Code Number or Get the IEC Number
  • Appoint distributors or agents, or you have to register an office in the country to export
  • Get the specifics, and terms and conditions signed off by the agent or wholesaler
  • Register your product in the nation you are exporting
  • Get the endorsement for export from DCGI
  • Formulize the shipping method, delivery terms, and payment mode
  • Get Purchase Order
  • Send a Pro-forma invoice with details such that sort of packing, freight details, rate, etc.
  • Get commercial invoice against Letter of Credit or Purchase Order
  • Sign agreement with the freight forwarding agency to dispatch the material to a particular country
  • Send products to custom clearance
  • After getting clearance, the material will be shipped
  • In the importing country, customs clearance is needed

Guide for applying for IEC to export medicines from India

Procedure to apply for IEC Number which is needed to export medicines from India.

Step 1: Go to the official website of the Directorate General of Foreign Trade

Step 2: Click on the ‘Online Application’ tab and choose the ‘IEC’ from the drop-down menu.

Step 3: Then select ‘Online IEC Application’

Step 4: Enter your PAN number to log in and click on the Next button.

Step 5: Go to File and pick new IEC Application details’

Step 6: Then a form will show up. Fill all the required details in the form and click on ‘Upload Documents’

Step 7: Once uploading the documents and filling the form, click on the ‘Branch’ button to add any branch details.

Step 8: Then click on ‘Director’ to fill in the details of the directors.

Step 9: Then click on ‘EFT’ for making an online payment.

Step 10: Fill in the number of details and select your bank to make a transaction.

Step 11: Then a draft invoice will show up. Check details you’ve entered and clicked on the ‘Pay now’ button.

Step 12: Make the payment by utilizing your internet banking details.

 

Mandatory Requirements to apply for IEC Number

  1. PAN Number
  2. Current Bank Account Details
  3. Bankers Certificate
  4. IEC Code Number Application Fee
  5. The paper copy of the application including essential documents should reach DGFT RLA concerned within 15 days of its online submission.

 

CUSTOM CLEARANCE

Customs clearance is another significant document that ought to be mandatorily obtained when you need to export medicines abroad.

.You can do it personally or enlist a customs clearance agent. Generate online shipping bills electronically. Thus, the material is moved to the shipping area where custom experts examine it.

Custom department issues ‘Let Export Order which implies the shipping bill can be printed.

These are two processes explained quickly. You need to collect complete data from reliable sources before moving further.

If you are looking for top PCD pharma companies in India then JoinHub Pharma is the best PCD pharma company in Ahmedabad located in Gujarat. We offer pharmaceutical franchises with extraordinary marketing support.

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-drugs
Generic Medicine Pharma Products

The Pros and Cons of Using Generic Drugs

According to the Food and Drug Administration (FDA), generic drugs are biologically equivalent to brand name drugs in dosage form, strength, safety, route of administration, quality, performance characteristics, and intended use. Basically, a generic drug is a copycat of a brand name medication (made after the patent from the brand name has ended). They’re likewise typically a more affordable solution.

Generic drugs seem to be getting more and more famous when it comes to significant brand name drugs, including many medications related to heart health like blood pressure and statins medication.

In fact, a record 86% of prescriptions dispensed in 2017 were for generic drugs versus brand-name drugs as per the IQVIA, one of the world’s largest contract research organizations.

Yet, exactly how safe is generic drugs when it comes to staying heart healthy? Let’s take a look at some of the pros and cons of generic medication below.

Pros:

    • Cheaper prices. The main reason so many people purchase generic drugs is that they are more cost-effective than brand name drugs. Brand name drugs require research and testing that take a lot of money and time, however, generic drugs only need to copy what as of now exists, saving them the cost and permitting the price to stay low.
    • Biologically speaking, generic drugs should satisfy precise guidelines so that the same amount of active ingredient is conveyed to the body simultaneously, and utilized by the body, in the same way as the brand name product.
    • FDA approved. The FDA sets severe guidelines and performs research on generic drugs to ensure that they are bioequivalent to the brand name.
    • Heart Healthy. As indicated by a recent study, generic heart medications show the same medical outcomes as brand name medications.

Cons:

    • Contamination. Generic drugs are frequently produced in factories in countries like China, India, or other areas with cheap labor and overhead. The conditions at these manufacturing plants have sometimes contaminated drugs, leading to recalls in the United States. To be reasonable, however, there have been a handful of situations where even US-based brand name drugs had similar issues although probably not nearly as frequently.
    • As per the report by the Government Accountability Office, these foreign factories sometimes escape rigorous FDA inspections, dodge documentation of their practices, and don’t get follow-up monitoring even when genuine manufacturing or drug-handling problems have been recognized. Generally, only one manufacturer produces a brand name drug whereas a couple of manufacturers can produce a generic drug. While the FDA insists on the bioequivalence of the active medication, there sometimes can be unpretentious differences in the delivery system of the drug or non-active “fillers” for the drug. These distinctions rarely result in any clinically significant issue for the patient despite the fact that in rare cases a patient might have a sensitivity or intolerance to an alternate filler or delivery system.
    • Mixing up the pills. As brand medications ordinarily have a consistent “branded” look to them that patients can get familiar and comfortable with, generics frequently don’t look as familiar or it isn’t as obvious what each pill seems to be. Moreover, when a prescription is refilled, if the drug is made by a different generic manufacturer and has a different appearance, this can prompt drug confusion and blunders or even patients not taking the pills they are recommended.
    • Doctors remain divided. Many medical experts are still divided on the utilization of generic drugs for heart disease, leaving some lingering doubt in this area. Some particular medications including thyroid supplements and blood thinners have had evidence of genuine clinically meaningful issues when switching between brand and generic or between different generics.

More and more frequently patients discover their brand name prescription medication won’t be covered by their insurance plan or their co-pay is higher. Regularly, the insurer will offer a generic version at a co-pay that is less. Luckily, at this point, the vast majority of cardiac medications are accessible in the generic form with commonly no obvious problems for the vast majority of patients.

When patients start on a new medication that is easily available from a generic drug manufacturer, it is usually recommended starting with the generic form if there is no scientific agreement that the brand name version is any better. While usually, the patient will likewise save money directly, we all benefit from the total reduction in health care costs. If a patient has been on a brand medication and can save cash by adopting the generic formulation or even a more affordable brand of the same drug class, it typically should be possible without any ill effects but we believe it ultimately ought to be the patient’s choice after consulting with their physicians. Many patients prefer not to “rock the boat” and not make the switch. While that is not unreasonable, one needs to weigh whether it is worth the additional expense.

If you have any questions or concerns about taking a generic versus a brand-name medication, reach out to us at JoinHub Pharma.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-drugs
Generic Medicine Pharma Products

The Mysteries Between The Branded Drugs Vs The Generic Drugs

Branded drugs are manufactured by an organization and are always sold under a brand name. Patents for such kinds of drugs can be obtained by including different inactive components to the drug, for example, flavoring and coloring agents.

Generic drugs are similar to branded drugs, yet they contain only the active components that are important to be included for the drug to be effective. Generic drugs don’t contain unnecessary inactive elements as branded drugs do. Generic drugs can be sold in the market once the branded drugs’ patents have lapsed, which is typically around 20 twenty years from the date of patent approval.

The Indian Pharma Market

India is perhaps the largest manufacturer of generic drugs globally. The Indian pharmaceutical sector industry supplies more than half of the global demand for different kinds of vaccinations. India holds a considerable position in the global pharmaceutical market as a supplier. The nation also consists of a large pool of scientists and engineers with the potential required to level the pharma industry up to a higher standard.

The Indian pharmaceutical market is foreseen to obtain the 9th position in the global market by 2023, thanks to different top-tier pharmaceutical companies that produce branded drugs that are sold highly in the market compared to generic drugs. Examples of some popular pharmaceutical companies include:

  • Sun Pharmaceutical Industries Limited
  • JoinHub Pharma
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Cipla Limited
  • Reddy’s Laboratories
  • Cadila Healthcare Limited
  • Intas Pharmaceuticals Limited

 

The Role of the FDA

The Food and Drug Administration department is actively taking part in the promotion of generic drugs worldwide, as it increases the availability of medicine at cheap prices.

Before launching a generic medicine in the market, the medicine must be approved by the FDA, who meticulously reviews the product and additionally guarantees that the drug meets certain standards applied for the approval of a branded drug. The department finds various steps to guarantee the safety and quality of drugs before and after it is launched in the market.

Even after the approval of any generic drug, the FDA keeps on observing the medicine’s level of safety to make sure that the products being sold to consumers are effective, safe, and of high quality. Thus, the FDA plays a significant part in offering quality medicine to those who require it, anywhere around the globe.

 

Difference between branded drugs and generic drugs

  • Branded drugs and generic drugs have similar active ingredients that are needed for the drug to be effective in nullifying the health condition. Branded and generic drugs are likewise similar when it comes to intake dosages and their strengths, with virtually no difference in their outcomes.
  • Branded drugs differ a lot from generic drugs in terms of size, shape, and color – this is generally done to facilitate patent approval, which needs a significant amount of distinction from existing drugs with comparative chemical compositions.
  • They are likewise discovered to have different inactive ingredients – branded drugs are heavy in content unrelated to the working of the drug, such as coloring and flavoring agents, on the other hand, generic drugs don’t include the utilization of gustatory and visual stimulation.
  • They are different in shapes, sizes, and colors.
  • They have different inactive ingredients. Most often only branded drugs have inactive components.
  • Generic drugs are more affordable than branded drugs.
  • Branded drugs are sold under a company’s name whereas generic drugs do not.

 

Clarifications:

Generic medication typically costs about 80% to 85% less than branded drugs. Generic drugs are less expensive because the manufacturer doesn’t have to develop and market a new drug, nor go through the troubles of researching, licensing, and getting it approved. It does not contain inactive components that are added to make them smell, look, and taste better, clearly leading to less expensive production costs.

  • Are generic drugs safe?

Indeed, Generic drugs are totally safe, as they are highly regulated and experience a rigorous review process before they are approved in the market. The Food and Drug Administration (FDA) tests the generic drugs to ensure that the drug is safe to be utilized by those afflicted with the disease being battled. The FDA only approves drugs if they meet all the guidelines for safe usage. After drug approval, the FDA will frequently inspect the manufacturing plant where the drug is manufactured and will monitor the drug for any safety concerns.

  • Why do branded drugs and generic drugs look different?

The shape, size, and color of the generic drugs and the branded drugs make them look unique.

 

Conclusion

It is apparent that Indian generic drug companies are growing at a fast pace. India is the biggest manufacturer of generic drugs in the world and thereby it helps to strengthen India’s burgeoning economy. A survey submitted by Global Business Report has stated that India’s pharma exports have increased by 11% in 2019, which is quite satisfactory. However, the popularity and demand for branded drugs in the market overpowers the presence of generic drugs.

Expensive branded medicines available in the market cannot be affordable by everyone. So, the Drug Price Control Order (DPCO) has decreased the price of some branded drugs. Regardless of this price reduction, a couple of branded drugs are still selling at high rates. Thus, the best alternative to these expensive branded drugs is generic drugs. The government must promote and advertise generic drugs to make them available to everyone. People should also start adopting generic medicines. Giving more into generic drugs will help them establish a strong presence in the market, which when combined with their cheap prices, will be the traction they require in the limit of pharmaceutical economies worldwide.

Get in touch with our experts at JoinHub Pharma today to know the pricing model of generic drugs.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-pharmaceutical
Pharmaceutical Manufacturing

Making the Case for Indian Generic Drug Manufacturing

American consumers are often amazed to find out about the drugs prescribed to them. For example, numerous individuals are taken aback to discover that more than 90% of the medicines prescribed by specialists in the U.S. are generics.

Considerably more surprising is the fact that in excess of 33% of these drugs were likely manufactured in India. This country’s ability to manufacture cost-effective, generic drugs has led to its reputation of being the “pharmacy of the world.” By export volume, India is presently the biggest supplier of generic medicines globally, providing 18% of global generic medicines.

It makes sense that when the media raises concerns about the safety and scope of imported and exported generic medicines, consumers question the quality of medicines fundamental to their health. Ongoing stories have depicted an industry laden with quality issues. These concerns raise fears among patients that consuming medicines made in India may bring about unpredictable effects.

Luckily, the generic medicines manufactured in India are as safe and efficacious as those produced in the United States.

In the past few years, expectations of regulatory organizations around the globe have increased. With the number of companies and manufacturing facilities supplying to the regulated market growing fast, it is natural that the agencies are increasing their efforts. Since 50% of India’s pharmaceutical exports are too highly regulated markets such as the United States, Indian manufacturers must comply with severe U.S. Food and Drug Administration (FDA) guidelines that incorporate regular and rigorous inspections to guarantee compliance.

Also, Indian manufacturers are being examined by inspectors from every market they export to — Mexico, South Korea, Germany, Japan, Brazil, to name a few — who regularly visit and assess Indian pharmaceutical factories.

In response to this growing regulatory environment, pharmaceutical companies in India keep on reinforcing their processes, while improving operating procedures, automation, and quality management systems. This incorporates vigorously proficient quality control and quality assurance systems close by workshops and training programs, building an omnipresent culture of quality. The outcome is a focus on quality that begins at a shop-floor level for machine operators, guaranteeing compliance from the ground up.

Redefining India’s reputation

So, what should be done in order to the practical steps being taken by Indian generic manufacturers to grasp a culture of high-quality? Significantly, beyond presenting a proof-based case that generics manufactured in India are efficacious and safe, we should likewise show the huge great these drugs provide to consumers.

For instance, Indian generic drug manufacturers play an important role in bringing safe, new, affordable drugs to US consumers. In 2018 alone, the FDA affirmed a record of 741 generic drugs with Indian organizations, representing almost 50% of the approvals. (Indian companies got 73 tentative approvals and a total of 415 product approvals in 2018.)

Consider that the Indian pharmaceutical industry has altogether reduced the burden on the U.S. public health system by making genuinely necessary medicines affordable and readily accessible. Every third tablet sold in the U.S. comes straight from India. Generic drug savings added up to $292.6 billion in 2018, as per the AAM Access & Savings Report (2019). Of this, expected savings adding up to $80 billion in 2017 can be credited to the contributions from Indian generic companies.

Indeed, Indian pharmaceutical companies are presently turning into a key source of medication for the rest of the developing world.

India’s global reach

The worldwide demand for medication from India will keep on going up. India’s share of the US generic market is growing quickly, and the number of organizations and manufacturing facilities supplying to the U.S. market is growing too fast. The focus on improved healthcare infrastructure, growing regulatory necessities, and surge in research and development spend bodes well for the pharma business.

This growth isn’t exclusive to India. Indian generic manufacturers are additionally producing in the U.S. and in other countries at whatever point necessary. The Indian Pharmaceutical Alliance (IPA) accounts for 23 research-based national pharmaceutical companies centered with respect to patient health and safety with a pledge to give quality drugs to patients throughout the world.

To drive forward this commitment to give high-quality and safe drugs, IPA organizations have attempted a few focused steps towards excellence in quality. Over the past 4 years, IPA has worked towards:

  • Benchmark Indian pharma drug quality with the rest of the world
  • Create targeted guidelines and best practices in areas of significant, which are vetted by regulators over the world, including the FDA
  • Expand the capabilities and skills of quality talent for Indian pharmaceutical companies

Moreover, between 2012 and 2016, IPA companies contributed $161 million to generic-drug user fees, subsequently offering more than half of the revenue under the Generic Drug User Fee Amendments, which empowers the FDA to bring more prominent predictability and timeliness to the review of generic drug applications, just as assists with funding the inspection of generic plants.

In conclusion

Indian companies will keep on expanding globally, enriching their manufacturing capabilities to fulfill the growing demand on the planet. The future will see a significant role in worldwide healthcare by Indian pharma, not only in making medicines affordable, yet in addition to reinforcing India’s position as a worldwide hub for making innovative and high-quality medicines.

By making key strategic moves in uncharted geographies, technologies, and products, Indian generic manufacturers look to recover their position as a world-class provider of affordable, excellent drugs. Guaranteeing we communicate this vision and quality-centric focus will be essential to the splendid future between manufacturers and those who depend on these medicines.

All things considered, a clear and concise understanding of our record of achievement and emphasis on quality supports the continuous efforts of Indian generic manufacturers to give quality solutions that eventually benefit consumers across the globe.

We at JoinHub Pharma offer 1000+ high-quality pharmaceutical drugs, generic medicines in India, and other countries like. Contact us today!

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Indian Pharma Industry
Pharmaceutical Company

The Pharmaceutical Industry in India: Invest in Pharma Sector

India is a prominent and rapidly growing nation in global pharmaceuticals. It is considered as the biggest supplier of generic medicines globally, occupying nearly 20% share in global supply by volume, and furthermore supplies 62% of global demand for vaccines. India positions 3rd worldwide for production by volume and 14th by value. India is the only nation with the biggest number of US-FDA-compliant Pharma plants which includes 262+ APIs. India has in excess of 2000 WHO-GMP approved pharma plants, 253+ European Directorate of Quality Medicines (EDQM) affirmed plants with modern cutting-edge technology.

India is the primary source of 60,000 generic brands across 60+ therapeutic categories and manufactures more than 500 various Active Pharmaceutical Ingredients (APIs). The API industry is ranked 3rd largest in the world presenting nearly 57% of APIs to the WHO prequalified list.

The nation is home to in excess of 3,000+ pharma organizations with a solid network of more than 10,500 manufacturing facilities.

  • From 2018-19, India’s pharmaceuticals exports were worth around $19.3 billion with a growth of 10.72% consistently.
  • India holds 12% of all worldwide manufacturing sites catering to the US market.
  • The expense of manufacturing in India is roughly 33% lower than.

Market Size

Indian pharmaceutical sector is extended to grow to US$ 100 billion, while the medical device market is foreseen to grow US$ 25 billion by 2025. Pharmaceuticals exports from India represent at US$ 20.70 billion in the Financial year 2020. Pharmaceutical exports incorporate intermediates, drug formulations, bulk drugs, herbal, and biologicals products.

India’s biotechnology industry involving bio-agriculture, biopharmaceuticals, bio-services, bioinformatics, and bio-industry is anticipated to grow at a normal growth rate of around 35% consistently to reach US$ 100 billion by 2025.

India’s domestic pharmaceutical market turnover reached roughly Rs 1.4 lakh crore in 2019, up 9.8% every year from Rs 129,015 crore (US$ 18.12 billion) in 2018.

Investments and Recent Developments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) strategy in the pharmaceutical sector in order to permit FDI up to 100% under the automatic route for the manufacturing of medical devices subject to particular issues.

As per the data released by the Department for Promotion of Industry and Internal Trade (DPIIT), The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 16.50 billion between April 2000 and March 2020.

Some of the recent developments/investments in the Indian pharmaceutical sector are as per the following:

  • During December 2019, on a moving annual total (MAT) basis, industry growth was at 9.8%, with price growth at 5.3%, new product growth at 2.7%, while volume growth at 2% y-o-y.
  • The Healthcare sector observed private equity of a total of US$ 1.1 billion with 27+ deals in H12019.
  • Indian pharmaceutical industry’s export to the US will get a lift as branded drugs worth US$ 55 billion will become off-patent during 2017-2019.

Growth Drivers

  • Innovation and R&D
    • To develop new complex generic drugs, enhanced by the New Drugs and Clinical Trial Rules, 2019 and the Atal Innovation Mission (a Government of India initiative with the targets of entrepreneurship and innovation promotion via competition, mentorship, etc.)
  • Medical tourism
    • Quality services at marginal expenses compared to Europe, US, and South Asia.
  • Infrastructure development
    • India has the most noteworthy number of US-FDA compliant plants outside the US.
  • Strong drug manufacturing
    • Expertise in low cost generic patented drugs and a movement towards end-to-end production.
The pharmaceutical industry in India provides a couple of opportunities for investments and trade due to the following factors:
  1. Concerning India’s huge population it is an excellent center for clinical trials.
  2. India has productive and cost-effective sources for taking a few to get back generic drugs, particularly the drugs that are going off their patents in the coming years.
  3. India has abundant manpower with solid technical, scientific knowledge.
  4. The cost required for research and development is extremely low.
  5. India houses magnificent laboratories with world-class facilities. It has labs that specialize in process development and the development of cost-efficient drug manufacturing technology.
  6. India is self-sustaining in terms of the manufacturing of bulk drugs. Practically 70% of the requirements for the formulation of drugs are accessible within the nation itself.
  7. India’s fast-growing biotech industry, which offers extraordinary potential in the worldwide market, likewise has contributed to making the pharma sector in India an appealing industry to make investments.

Due to all these advantageous elements, India is recognized as one of the leading players in pharmaceuticals in the worldwide market.

Road Ahead

Medicine spending in India is anticipated to grow 9-12% over the next five years, driving India to become one of the best 10 countries in terms of medical spending.

Going ahead, better growth in domestic sales would likewise rely upon the ability of organizations to align their product portfolio towards chronic therapies for diseases such as anti-diabetes, antidepressants, cardiovascular, and anti-cancers, which are on the rise.

The Indian Government has found a way to reduce costs and cut down healthcare expenses. The rapid introduction of generic drugs into the market has stayed in focus and is needed for the growth of Indian pharmaceutical companies. Moreover, the thrust on rural wellbeing programs, life-saving medications, and preventive vaccines additionally foreshadow well for pharmaceutical companies.

With such an exceptional initiative of the Indian government, the Indian pharmaceutical industry looks incredibly positive for attracting more foreign investments.

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-drug
Pharma Products Pharmaceutical Manufacturing

Top 5 Generic Drug Makers in India

The demand for generic drugs is increasing worldwide and pharmaceutical companies are realizing the great potential this opportunity affords. Efficient and Cheap drugs are always needed, making this a growing business sector for drugmakers. The global market for generic drugs is projected to rise at a compound annual growth rate (CAGR) of 8.7 percent; meaning that, in the forecast period 2016 to 2021, the global market will increase from $352 billion to $533 billion.1
In this article, the top five generic drug makers are listed by total revenue, measured in the financial year (FY) 2018. Counting down, they are as follows

JoinHub Pharma
JoinHub Pharma is an award-winning Pharmaceutical Company in India. We hold a reputed name with regards to branded medicines and generic medicines. Our company is certified by the highest authority like WHO, FDA, ISO 9001:2008, GMP, etc. We are a top pharma manufacturer known for our top of the line quality pharma products and services. Without a doubt, we are considered to be one of the best generic medicine manufacturers in India. In fact, 85% of our revenue is generated by way of exporting to MIDDLE EAST, CIS, and AFRICA production facilities. We are popular for our widest list of medicines which contains more than 1000+ pharma products.

The range of products we manufacture are:

● Tablet, Capsules and soft gel capsules, Injection, oral liquid, external
● preparations cream, ointments, suspensions, eye ear nasal drops in different
● therapeutic expertise CNS,
● Anticonvulsant, anti-diabetic, anticancer, antibiotics, antiviral, antibacterial,
● immunosuppressants,
● hormone, nutraceutical, derma care, probiotic, prebiotic, cough,
● expectorant, NSAIDs, nephrology and urology, oral contraceptives, gynecology,
● oral health care and many more

Every manufacturing is done in our company-owned GMP-WHO certified units. What makes us best to associate with and become our client?

Here are the points for consideration:

● Latest Packaging Technology like ALU-ALU is utilized.
● Manufacturing Agreement is kept transparent through clarified terms and
● conditions. It likewise incorporates Intellectual property Rights,
● We have a reputation for updating with long term relations.
● Widest range of 1000+ pharma items
● Skilled R&D team with completely furnished automated laboratory,
● Manufacturing happens in excise duty-free zones which make the business deal moderate.
● Approved pharma products from Food & Dry Administration (FDA) for every medicine
● Approvals from DCGI and FSSAI for all products
● Units and plants certified by well-known associations including Good
● Manufacturing Products (GMP) and the World Health Organization (WHO)
● Secrecy is maintained about the generic drug product formulation with everything being equal.
● Abbreviated New Drug Application (ANDA) approval to advertise a generic drug product has been taken care of by the organization itself.

Lupin Pharmaceuticals
This pharmaceutical company is based in Mumbai, India. Lupin Pharmaceuticals is a subsidiary of Lupin Limited and one of the top five pharmaceutical companies in the country, making it a key player in the industry. The company was founded in 1968 and while its main focus is generic drugs, it also manufactures branded medications and active pharmaceutical ingredients (API).

Sun Pharmaceuticals
Sun Pharmaceuticals, also headquartered in Mumbai and has over 2,000 marketed products. According to Sun Pharmaceuticals, they have built a portfolio of about 10 specialty products, five of which are already on the market. They expect that this side of their business will be a key driver in the coming financial year.5 In addition to being a leading generic drug maker, the company also provides a range of APIs. They invest heavily in R&D, using around 7-8 percent of their annual revenues to improve this side of their business. Established in 1983, Sun Pharma sold items across India before expanding globally in 1996.

Sandoz
Sandoz is a generic and biosimilar producer division of the Novartis Group. Headquartered in Munich, Germany,10 the company merged with Ciba-Geigy in 1996 to form Novartis. According to the company, a planned transformation for Sandoz through Novartis is expected to enable them to compete effectively in a more challenging environment by increasing their share of higher-margin differentiated products. The retail generics franchise amounted to 80% of the company’s total business, followed by biopharmaceuticals (15%) and anti-infectious (5%). Sandoz also offers a variety of drug delivery mechanisms.

Teva Pharmaceutical Industries Ltd
Based in Jerusalem, Israel, Teva is the world’s leading generic drug maker; yet it’s also active in ventures that include APIs. Teva manufactured nearly 120 billion tablets with one out of nine generic prescriptions in the US containing the organization’s products. Teva says that it has a unique understanding of local markets. Founded in 1901, Teva began as a small wholesale drug business distributing imported medications. In the 1980s, it then expanded internationally and entered the US market.18 With a specialty R&D program, the company says it has a “robust pipeline” of high-value medications

Conclusion
Generic drug makers have vast potential in the market and, due to the high demand for generics, significant profits exist to return investments. Opportunities for these companies provide the potential for even greater growth in the future, with the market set to increase soon.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK